All Articles

Browse the full archive, newest first.

Briefing: Meta’s deepfake moderation isn’t good enough, says Oversight Board

Strategic angle: Meta’s Oversight Board urges the company to enhance AI labeling to combat misinformation.

Briefing: Volkswagen flags a tough year ahead as 2025 profit halves on tariffs, China competition

Strategic angle: Volkswagen reported a more than 50% drop in annual operating profit, citing the impact of U.S. tariffs, currency effects and a strategic shift at Porsche.

Editorial Staff Mar 10

Politics

Briefing: Fears for women’s rights in Chile as anti-abortion president set to take office

Strategic angle: José Antonio Kast, who voted against legalising divorce in 2004, has pushed for return to total abortion ban.

Editorial Staff Mar 10

Money

Briefing: PFAS Waste Utilized for Lithium Extraction from Brine Pools

Strategic angle: Innovative use of PFAS waste shows potential in lithium extraction processes.

Editorial Staff Mar 10

Money

Briefing: Stellantis Taps Toyota, Bosch Suppliers for Hybrid Technologies for New Jeeps

Strategic angle: Jeep maker Stellantis is leaning on technologies from automotive suppliers for its newest hybrid vehicles, CNBC has learned.

Editorial Staff Mar 10

Life

Briefing: Subway systems are uncomfortably hot—and worsening, study finds

Strategic angle: A new study reveals that thermal discomfort in metro systems is increasing, impacting millions of commuters.

Editorial Staff Mar 10

Travel

Briefing: 'Credit Karma Is Nuts': Man Goes To Dealership To Buy A New Kia. Then The Car Salesman Realizes He Uses Credit Karma

Strategic angle: "I can't understand how you said you it was a 650 on Credit Karma."

Editorial Staff Mar 10

Politics

Briefing: GLP-1s have transformed weight loss and diabetes. Is addiction next?

Strategic angle: A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.

Editorial Staff Mar 10

Sports

Briefing: Inside Bodo/Glimt - the Champions League's ultimate giantkilling story

Strategic angle: It's early January and Bodo/Glimt are holding a team meeting in Spain to discuss their upcoming Champions League campaign.

Editorial Staff Mar 10

Life

Briefing: Large drugmakers are developing fewer antibiotics, analysis finds

Strategic angle: The number of potential antimicrobial treatments being developed by the world’s largest drugmakers nosedived by 35% over the past five years, according to a new analysis.

Editorial Staff Mar 10